HomeCare Guidelines

Care Guidelines

Duchenne Muscular Dystrophy Speech Delay: Understanding Language Development in Children with DMD

Duchenne muscular dystrophy speech delay is an important developmental concern that families and healthcare professionals should recognize. Although Duchenne muscular dystrophy (DMD) is primarily known as a genetic neuromuscular condition causing progressive muscle weakness, research has shown that some boys with DMD can also experience differences or delays in...

Guide to DMD for Parents and Teachers at School: A Complete Guide for Safety, Learning, Friendship and Inclusion

A well-structured guide to DMD for parents and teachers at school is essential for supporting children with Duchenne Muscular Dystrophy (DMD) in educational environments. DMD is a progressive neuromuscular condition that affects muscle strength, endurance, and sometimes cognitive functioning. These challenges directly influence how a child participates in school...
spot_img

Keep exploring

Gastrostomy Tubes in Duchenne Muscular Dystrophy (DMD): When Is a PEG Tube Needed, Benefits, Risks & Nutrition Guide

Gastrostomy tubes in Duchenne Muscular Dystrophy (DMD) have become an important component of multidisciplinary...

DMD Circumcision Guide: Safety Precautions, Anesthesia, and Aftercare

Parents often ask an important question after their child is diagnosed with Duchenne muscular...

Pain Management in Duchenne Muscular Dystrophy: A Parent’s Guide to Helping Your Child Live More Comfortably

Living with Duchenne muscular dystrophy (DMD) involves far more than progressive muscle weakness. One...

What Is a Spirometry Test in Duchenne Muscular Dystrophy (DMD) and Why Is It Performed?

A spirometry test in Duchenne muscular dystrophy is a simple, non-invasive breathing test used...

Age-Based Assistive Devices for Duchenne Muscular Dystrophy: Complete Guide by Stage

Age-based assistive devices for Duchenne muscular dystrophy (DMD) plays a critical role in preserving...

Breathing Exercises in Duchenne Muscular Dystrophy: Respiratory Therapy, Pulmonary Care & Lung Support

Duchenne muscular dystrophy (DMD) is a severe progressive neuromuscular disorder that gradually weakens skeletal,...

Care of Non-Ambulatory Patients with Duchenne Muscular Dystrophy: Complete Guide

Care of non-ambulatory patients with Duchenne muscular dystrophy (Who use a wheelchair) is a...

Peak Flow Meter in Duchenne Muscular Dystrophy: Complete Respiratory Monitoring Guide

Peak flow meter in Duchenne muscular dystrophy (DMD) is an increasingly important topic in...

Psychological Support in DMD: Coping Strategies for Families and Children After Diagnosis

Psychological support in Duchenne muscular dystrophy (DMD) is a critical and often underemphasized aspect...

Enlarged Calf Muscles in Duchenne Muscular Dystrophy: Causes, Symptoms & Treatment

Enlarged calf muscles in Duchenne muscular dystrophy are one of the most recognizable early...

Constipation in Duchenne Muscular Dystrophy: Causes, Symptoms & Treatment

Constipation in Duchenne muscular dystrophy (DMD) is a common but often under-recognized complication that...

Calcium in Duchenne Muscular Dystrophy: Mechanisms, Risks, and Treatment Insights

Calcium in Duchenne muscular dystrophy (DMD) plays a central role in disease progression, muscle...

Latest articles

Duchenne Muscular Dystrophy Speech Delay: Understanding Language Development in Children with DMD

Duchenne muscular dystrophy speech delay is an important developmental concern that families and healthcare...

Keros Therapeutics Doses First Patient in Phase 2 Rinvatercept Trial

Keros Therapeutics has announced an important step in the development of Rinvatercept, an investigational...

The Systemic Failure of DMD Associations: Why Duchenne Patients Are Still Waiting

Duchenne muscular dystrophy (DMD) is not a newly discovered condition, nor is it an...

In Which Countries Is Elevidys Approved? Is Elevidys Approved In Europe?

Elevidys (delandistrogene moxeparvovec) is a gene therapy developed for Duchenne muscular dystrophy (DMD). It...

Exegenesis Bio and Modalis Collaborate to Advance MDL-201 for Duchenne Muscular Dystrophy

Exegenesis Bio and Modalis Therapeutics Corporation have announced a research collaboration and license agreement...

Tevard’s tRNA Therapy Targets Nonsense Mutations to Restore Full-Length Dystrophin in DMD

Tevard’s suppressor tRNA therapy could offer a new way to address nonsense mutations in...

Satellos’ Duchenne Drug SAT-3247 Receives Official WHO Name: Forazapadin

Satellos Bioscience has announced that its investigational Duchenne muscular dystrophy (DMD) treatment SAT-3247 has...

FDA Accepts Del-zota Application for Priority Review in DMD44

The U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA)...